+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Contribution of BRCA1 and BRCA2 mutations to hereditary breast/ovarian cancer



Contribution of BRCA1 and BRCA2 mutations to hereditary breast/ovarian cancer



Gynecologic Oncology 68(1): 110




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030702928

Download citation: RISBibTeXText


Related references

Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2. Genetics in Medicine 12(5): 245-259, 2010

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. Clinical Cancer Research 9(10 Pt 1): 3606-3614, 2003

BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer. Acta Oncologica 47(4): 772-777, 2008

A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families. Casopis Lekaru Ceskych 139(20): 635-637, 2001

Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families. International Journal of Oncology 41(5): 1619-1627, 2013

BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer. Wiener Medizinische Wochenschrift 160(7-8): 158-162, 2010

Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. American Journal of Human Genetics 71(3): 595-606, 2002

Germline mutations in BRCA1 and BRCA2 genes in the Czech hereditary forms of breast/ovarian cancer. European Journal of Human Genetics 10(Supplement 1): 83, 2002

Analysis of BRCA1 and BRCA2 mutations in an Iranian family with hereditary breast and ovarian cancer syndrome. American Journal of Medical Genetics. Part a 117a(3): 304-305, 2003

Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families. Neoplasma 53(2): 97-102, 2006

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115(10): 2222-2233, 2009

Prevalence of BRCA1 and BRCA2 founder mutations in Brazilian hereditary breast and ovarian cancer families. Journal of Clinical Oncology 26(15_suppl): 22108-22108, 2016

Common BRCA1 and BRCA2 mutations in hereditary breast-ovarian cancer families of French-Canadian population. Proceedings of the American Association for Cancer Research Annual Meeting 39: 475, 1998

High rate of germline mutations in BRCA1 and BRCA2 genes in the Czech hereditary forms of breast/ovarian cancer. European Journal of Human Genetics 9(Supplement 1): P0065, 2001

Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer. Peerj 7: E6661, 2019